Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
- May - June - July - August - September - Oktober - November - December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
- 2025
May 2025 - 25 products
IP
Fluaze Leman
25 ml
PR
PR
k.A.
Leman SKL SA
B
FB
G
Spevigo 150 mg/1ml
2
PR
PR
k.A.
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
V/S
Vaxigrip
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
V/S
Vaxigrip
10
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
Ondansetron Spirig HC 4 mg
10
PR
PR
k.A.
Schmelztabletten: Ondansetronum 4 mg
Spirig HealthCare AG
B
FB
G
Ondansetron Spirig HC 8 mg
6
PR
PR
k.A.
Schmelztabletten: Ondansetronum 8 mg
Spirig HealthCare AG
B
FB
G
Ondansetron Spirig HC 8 mg
10
PR
PR
k.A.
Schmelztabletten: Ondansetronum 8 mg
Spirig HealthCare AG
B
FB
G
Tofidence 80 mg/4 ml
PR
PR
k.A.
Infusionskonzentrat: Tocilizumabum 80mg / 4ml
Biogen Switzerland AG
A
FB
G
Tofidence 200 mg/10 ml
PR
PR
k.A.
Infusionskonzentrat: Tocilizumabum 200mg / 10ml
Biogen Switzerland AG
A
FB
G
Tofidence 400 mg/20 ml
PR
PR
k.A.
Infusionskonzentrat: Tocilizumabum 400mg / 20ml
Biogen Switzerland AG
A
FB
G
Tofidence 80 mg/4 ml
4
PR
PR
k.A.
Infusionskonzentrat: Tocilizumabum 80mg / 4ml
Biogen Switzerland AG
A
FB
G
Tofidence 200 mg/10 ml
4
PR
PR
k.A.
Infusionskonzentrat: Tocilizumabum 200mg / 10ml
Biogen Switzerland AG
A
FB
G
Tofidence 400 mg/20 ml
4
PR
PR
k.A.
Infusionskonzentrat: Tocilizumabum 400mg / 20ml
Biogen Switzerland AG
A
FB
G
IP
CI
Evrysdi 5 mg
28
PR
PR
k.A.
Filmtabletten: Risdiplamum 5 mg
Roche Pharma
(Schweiz) AG
A
FB
G
Celecoxib-Mepha Teva 100 mg
30
PR
PR
k.A.
Kapseln: Celecoxibum 100 mg
Mepha Pharma AG
B
FB
G
Celecoxib-Mepha Teva 200 mg
30
PR
PR
k.A.
Kapseln: Celecoxibum 200 mg
Mepha Pharma AG
B
FB
G
Celecoxib-Mepha Teva 200 mg
100
PR
PR
k.A.
Kapseln: Celecoxibum 200 mg
Mepha Pharma AG
B
FB
G
ASS Cardio Sandoz 100 mg
30
PR
PR
k.A.
Magensaftresistente Tabletten: Acidum Acetylsalicylicum 100 mg
Sandoz
Pharmaceuticals AG
B
FB
G
ASS Cardio Sandoz 100 mg
100
PR
PR
k.A.
Magensaftresistente Tabletten: Acidum Acetylsalicylicum 100 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
DATROWAY 100 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Datopotamabum Deruxtecanum 100 mg
Daiichi Sankyo
(Schweiz) AG
A
FB
G
Sapropterin NOBEL 100 mg
30
PR
PR
k.A.
Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mg
NOBEL Pharma Schweiz AG
B
FB
G
Edurant 2.5 mg
90
PR
PR
k.A.
Tabletten zur Herstellung einer Suspension zum Einnehmen: Rilpivirinum 2.5 mg
Janssen-Cilag AG
A
FB
G
IP
Dimetindene Leman 1 mg/ml
20 ml
PR
PR
k.A.
solution buvable en gouttes: Dimetindeni Maleas 1 mg/ml
Leman SKL SA
D
FB
G
IP
Dimetindene Leman 1 mg/ml
50 ml
PR
PR
k.A.
solution buvable en gouttes: Dimetindeni Maleas 1 mg/ml
Leman SKL SA
D
FB
G
IP
Dimetindene Leman 1 mg/ml
3 x 20 ml
PR
PR
k.A.
solution buvable en gouttes: Dimetindeni Maleas 1 mg/ml
Leman SKL SA
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
